9.80
0.07 (0.72%)
| 前收盘价格 | 9.73 |
| 收盘价格 | 9.68 |
| 成交量 | 4,077,528 |
| 平均成交量 (3个月) | 2,589,818 |
| 市值 | 2,928,299,008 |
| 预期市盈率 (P/E Forward) | 59.17 |
| 价格/销量 (P/S) | 5.65 |
| 股市价格/股市净资产 (P/B) | 15.39 |
| 52周波幅 | |
| 利润日期 | 26 Feb 2025 - 3 Mar 2025 |
| 营业毛利率 | -21.21% |
| 营业利益率 (TTM) | 17.53% |
| 稀释每股收益 (EPS TTM) | -0.340 |
| 季度收入增长率 (YOY) | 36.70% |
| 总债务/股东权益 (D/E MRQ) | 248.66% |
| 流动比率 (MRQ) | 3.15 |
| 营业现金流 (OCF TTM) | -26.52 M |
| 杠杆自由现金流 (LFCF TTM) | -10.72 M |
| 资产报酬率 (ROA TTM) | 1.16% |
| 股东权益报酬率 (ROE TTM) | -67.09% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Amicus Therapeutics, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -1.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.13 |
|
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.76% |
| 机构持股比例 | 104.43% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 21.00 (Cantor Fitzgerald, 114.29%) | 购买 |
| 中 | 15.00 (53.06%) | |
| 低 | 12.00 (Morgan Stanley, 22.45%) | 保留 |
| 平均值 | 16.00 (63.27%) | |
| 总计 | 4 购买, 1 保留 | |
| 平均价格@调整类型 | 10.76 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Morgan Stanley | 13 Dec 2024 | 12.00 (22.45%) | 保留 | 9.36 |
| JP Morgan | 12 Nov 2024 | 17.00 (73.47%) | 购买 | 10.49 |
| Cantor Fitzgerald | 07 Nov 2024 | 21.00 (114.29%) | 购买 | 10.98 |
| Guggenheim | 07 Nov 2024 | 15.00 (53.06%) | 购买 | 10.98 |
| B of A Securities | 17 Oct 2024 | 15.00 (53.06%) | 购买 | 11.97 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合